Related Experiment Video
Updated: Apr 6, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial
Adam M Garber1, Robert J Mentz2, Hussein R Al-Khalidi3
1Department of Internal Medicine, Virginia Commonwealth University, 1200 East Broad St., P.O. Box 980102, Richmond, VA, 23298-0102, USA. agarber@mcvh-vcu.edu.
Insights
Left ventricular thrombus (LVT) after ST-segment elevation myocardial infarction (STEMI) is predicted by higher heart rate, non-white race, heart failure severity, and LAD disease. Further research is needed to confirm if anticoagulation improves outcomes in high-risk patients.
Area of Science:
- Cardiology
- Clinical Medicine
- Medical Research
Background:
- Left ventricular thrombus (LVT) formation after ST-segment elevation myocardial infarction (STEMI) lacks well-defined contemporary predictors.
- Understanding these predictors is crucial for risk stratification and management.
Purpose of the Study:
- To identify independent predictors of LVT following STEMI.
- To investigate the association between LVT and long-term mortality in STEMI patients.
Main Methods:
- Retrospective analysis of 1734 STEMI patients undergoing echocardiography within 90 days post-STEMI (2000-2011).
- Cox proportional hazards regression models were used to identify independent predictors of LVT.
- Multivariable survival models assessed the association between LVT and all-cause mortality.
Main Results:
- 4.3% of patients developed LVT.
- Independent predictors of LVT included higher heart rate, non-white race, heart failure severity, and left anterior descending artery (LAD) disease.
- A trend towards increased all-cause mortality was observed in patients with LVT, but it was not statistically significant.
Conclusions:
- Higher heart rate, non-white race, heart failure severity, and LAD disease are independent predictors of LVT post-STEMI.
- Prospective studies are warranted to evaluate the efficacy of anticoagulation in high-risk LVT patients.
Abstract:
We aimed to characterize the independent predictors of LVT following STEMI and the association with outcomes. The clinical predictors of left ventricular thrombus (LVT) formation after ST-segment elevation myocardial infarction (STEMI) are not well-defined in the contemporary era. We performed a retrospective analysis of STEMI patients at Duke from 2000 to 2011 who had a transthoracic echocardiogram within 90 days post-STEMI and compared patients with and without LVT (LVT+ vs. LVT-). Univariate Cox proportional hazards regression models of baseline characteristics were examined and significant variables were used in a multivariable model to assess adjusted relationships with LVT. A multivariable Cox PH survival model with covariate adjustments was used for assessment of LVT and long-term mortality. Of all eligible patients, 1734 patients met inclusion criteria and 4.3 % (N = 74) had a LVT. LVT+ patients tended to have a history of heart failure (HF) and higher initial troponin compared to LVT- patients. After adjustment, higher heart rate, non-white race, HF severity, and presence of left anterior descending artery (LAD) disease were independent predictors of LVT. There was a trend toward an association between LVT and increased all-cause mortality (HR 1.36; 95 % CI 0.84-2.21, P = 0.22), however this was not statistically significant. LVT was seen in over 4 % of this contemporary post-STEMI population. Several baseline characteristics were independently associated with LVT: Heart rate, HF severity, LAD disease, and non-white race. Prospective studies are warranted to determine whether anticoagulation in patients at increased risk for LVT improves outcomes.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Mitral Stenosis II: Clinical features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests